What is the most recent earnings date for UBX stock?
UNITY BIOTECHNOLOGY INC (UBX) last reported earnings on 4/22/2025.
NASDAQ:UBX • US91381U2006
Past quarterly earnings results for UNITY BIOTECHNOLOGY INC (UBX), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q1 2025 | -0.43 | -0.40 | -6.44% | -26.47% | - | - | ||
| Q4 2024 | -0.50 | -0.41 | -22.33% | -78.57% | 6.733M | -100.00% | - | |
| Q3 2024 | -0.38 | -0.42 | 8.68% | 42.42% | - | - | ||
| Q2 2024 | -0.31 | -0.47 | 33.56% | 63.53% | - | - | ||
| Q1 2024 | -0.34 | -0.48 | 29.48% | 55.26% | - | - | ||
| Q4 2023 | -0.28 | -0.73 | 61.55% | 72.00% | - | - | ||
| Q3 2023 | -0.66 | -0.97 | 32.05% | 51.47% | - | - | ||
| Q2 2023 | -0.85 | -0.86 | 1.71% | 55.26% | - | -100.00% | ||
| Q1 2023 | -0.76 | -1.09 | 30.58% | 72.86% | - | - | ||
| Q4 2022 | -1.00 | -1.06 | 5.55% | 44.44% | - | -100.00% | ||
| Q3 2022 | -1.36 | -1.66 | 18.23% | 54.67% | - | - | ||
| Q2 2022 | -1.90 | -2.83 | 32.77% | 40.63% | 236K | - | - | |
| Q1 2022 | -2.80 | -2.60 | -7.77% | 3.45% | - | - | ||
| Q4 2021 | -1.80 | -3.89 | 53.71% | 51.35% | 4.784M | - | - | |
| Q3 2021 | -3.00 | -3.75 | 20.02% | 42.31% | - | - | ||
| Q2 2021 | -3.20 | -3.10 | -3.07% | 15.79% | - | - | ||
| Q1 2021 | -2.90 | -3.83 | 24.34% | 46.30% | - | - | ||
| Q4 2020 | -3.70 | -4.76 | 22.29% | - | - | - | ||
| Q3 2020 | -5.20 | -4.96 | -4.86% | - | - | - | ||
| Q2 2020 | -3.80 | -5.17 | 26.43% | - | - | - | ||
| Q1 2020 | -5.40 | -5.12 | -5.52% | - | - | - |
Notes
UNITY BIOTECHNOLOGY INC (UBX) last reported earnings on 4/22/2025.
UNITY BIOTECHNOLOGY INC (UBX) missed EPS estimates and missed revenue estimates in the most recent quarter.
In the last 4 quarters, UNITY BIOTECHNOLOGY INC (UBX) has beaten EPS estimates in 2 out of 4 releases.